Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Maejima

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Frontiers in Cardiovascular Medicine|May 16, 2022
Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature ReviewKeita Watanabe, Takashi Ashikaga, Yasuhiro Maejima, et al.
The Journal of Clinical Investigation|December 5, 2018
An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemiaToshiro Saito, Jihoon Nah, Shin-Ichi Oka, et al.
Arthritis Research & Therapy|April 9, 2020
Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesionsTakahiko Sugihara, Hitoshi Hasegawa, Haruhito A Uchida, et al.
Modern Rheumatology|December 1, 2021
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitisTakahiko Sugihara, Yoshikazu Nakaoka, Haruhito A Uchida, et al.
Tropical Medicine and Health|December 8, 2023
Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responsesKatherine-Sofia Candray-Medina, Yu Nakagama, Masamichi Ito, et al.
Plos One|August 28, 2025
Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocolRyo Tateishi, Shinsuke Miyazaki, Kazuya Yamao, et al.
Rheumatology (Oxford, England)|January 18, 2020
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT studyYoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 11, 2024
Clinical Characteristics and Treatment Outcomes of Patients With Newly Diagnosed Takayasu Arteritis in Japan During the First 2 Years of Treatment - A Nationwide Retrospective Cohort StudyHaruhito A Uchida, Yoshikazu Nakaoka, Takahiko Sugihara, et al.
Frontiers in Cardiovascular Medicine|December 6, 2021
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in JapanSeiya Oba, Tadashi Hosoya, Miki Amamiya, et al.
American Journal of Human Genetics|July 9, 2013
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese populationChikashi Terao, Hajime Yoshifuji, Akinori Kimura, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Frontiers in Cardiovascular Medicine|May 16, 2022
Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature ReviewKeita Watanabe, Takashi Ashikaga, Yasuhiro Maejima, et al.
The Journal of Clinical Investigation|December 5, 2018
An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemiaToshiro Saito, Jihoon Nah, Shin-Ichi Oka, et al.
Arthritis Research & Therapy|April 9, 2020
Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesionsTakahiko Sugihara, Hitoshi Hasegawa, Haruhito A Uchida, et al.
Modern Rheumatology|December 1, 2021
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitisTakahiko Sugihara, Yoshikazu Nakaoka, Haruhito A Uchida, et al.
Tropical Medicine and Health|December 8, 2023
Differential cardiomyocyte transcriptomic remodeling during in vitro Trypanosoma cruzi infection using laboratory strains provides implications on pathogenic host responsesKatherine-Sofia Candray-Medina, Yu Nakagama, Masamichi Ito, et al.
Plos One|August 28, 2025
Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocolRyo Tateishi, Shinsuke Miyazaki, Kazuya Yamao, et al.
Rheumatology (Oxford, England)|January 18, 2020
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT studyYoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 11, 2024
Clinical Characteristics and Treatment Outcomes of Patients With Newly Diagnosed Takayasu Arteritis in Japan During the First 2 Years of Treatment - A Nationwide Retrospective Cohort StudyHaruhito A Uchida, Yoshikazu Nakaoka, Takahiko Sugihara, et al.
Frontiers in Cardiovascular Medicine|December 6, 2021
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in JapanSeiya Oba, Tadashi Hosoya, Miki Amamiya, et al.
American Journal of Human Genetics|July 9, 2013
Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese populationChikashi Terao, Hajime Yoshifuji, Akinori Kimura, et al.
Pageof 13